Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™
Clinical trial NCT03936426 · COMPLETED
Trial details
- NCT number
- NCT03936426
- Sponsor
- Clarity Pharmaceuticals Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-09
- Primary completion
- 2019-09-19
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.